Skip to main content

Alexandra G. Calistri

  • Successfully defended Neurotrope Biotechnology Inc in a securities class action case. The Mintz team achieved a complete victory at the motion to dismiss stage.
Case Study
Mintz secured dismissal of a securities fraud case against biopharmaceutical company Neurotrope. Mintz argued that securities laws do not require disclosure of the statistical methodology behind announced clinical trial results.